July 6, 2017 | Israeli medical device company, Theranica Bio-electronics, has completed a $6 million Series A funding round led by Lightspeed Venture Partners. The funding will support the regulatory process and mass manufacturing of their wireless and electronic technologies to treat migraines. CEO Alon Ironi founded the company in 2016 with hopes of combining neuromodulation therapy with modern wireless technology.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli Cybersecurity Startup To Provide Training For IDF
October 10, 2024
Johnson & Johnson Completes Purchase Of Israeli Startup V-Wave
October 10, 2024
Weizmann Researchers Create Biodegradable Composite Plastic
October 09, 2024
IIA Funds Further Israeli R&D Into Crustacean Gene Modification
October 09, 2024
Facebook comments